United States · FDA National Drug Code directory
PHOSPHA 250 NEUTRAL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64980-729_f6c34864-dbd6-436e-b1e5-b1feaa61696a
- Product NDC
- 64980-729
- Form
- TABLET
- Composition / generic term
- Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20260328
- Source listing expiry
- 20271231
Source-listed ingredients
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS — 852 mg/1
- POTASSIUM PHOSPHATE, MONOBASIC — 155 mg/1
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE — 130 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (64980-729-01) · 64980-729-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →